
P&G Hygiene Q2 FY27: standalone PAT down 6.7% YoY on margin compression, revenue flat
Procter & Gamble Hygiene and Health Care's Q2 FY27 standalone revenue was ₹1,145.08 Cr, down 0.44% YoY from ₹1,150.17 Cr and up 28.5% QoQ from ₹891.46 Cr. The sequential jump is a festive-quarter seasonal pattern typical of this FMCG franchise and should not be read as a trend reversal — YoY is flat, not growing. Standalone PAT was ₹195.84 Cr, down 6.7% YoY from ₹209.86 Cr, even as it rose 55.1% QoQ off Q1's depressed ₹126.27 Cr base; that QoQ strength is a low-base/seasonal artifact, not a turnaround. EPS was ₹60.33 versus ₹64.65 a year ago. Revenue came in well ahead of Street: MOFSL had modelled Q2 revenue near ₹1,000 Cr, so the print beat that estimate by roughly 14-15%; no third-party PAT estimate could be located for cross-check. Operating margin (PBT + finance cost + depreciation − other income, over revenue) was 22.72%, down from 24.76% a year ago (-204 bps), while net margin (PAT/total income) was 16.85% versus 18.09% (-124 bps). The compression traces to raw-material-and-traded-goods costs, which rose to 41.1% of revenue from 38.7% a year ago — a continuation of the commodity-cost pressure management flagged on the Q1 FY27 call, when it attributed a 34.3% YoY PAT decline and a 933-bps EBITDA margin collapse to geopolitically-driven crude and resin cost inflation. This quarter's YoY margin and profit erosion is materially smaller than Q1's, suggesting the worst of the commodity pass-through lag may be easing. Advertising & sales promotion spend was ₹166.62 Cr (14.55% of revenue), down slightly from ₹175.97 Cr (15.30% of revenue) a year ago, even though it nearly doubled sequentially from Q1's ₹83.32 Cr — again a seasonal festive-quarter step-up rather than a new elevated spending stance. The company has not issued formal quantitative guidance (no prior concall read or guidance figure on record), so this result cannot be graded against a specific numeric target. Qualitatively, management said on the Q1 call that commodity-cost challenges would persist through FY27 while expressing confidence in its growth strategy; this quarter's continued but narrower margin compression is consistent with, not contradictory to, that framing. The filing confirms (Note 8) the company has no subsidiary, associate or joint venture, so standalone is the complete and only reported basis — there is no separate consolidated number to reconcile against, and no exceptional items or one-off charges appear in the statement.
Key Highlights
- Standalone PAT ₹195.84 Cr, down 6.7% YoY (vs ₹209.86 Cr); revenue ₹1,145.08 Cr, down 0.44% YoY (vs ₹1,150.17 Cr)
- QoQ: revenue +28.5%, PAT +55.1% off Q1's depressed base (₹891.46 Cr / ₹126.27 Cr) — a festive-season seasonal effect, not a trend reversal
- OPM compressed to 22.72% from 24.76% YoY (-204 bps); NPM to 16.85% from 18.09% YoY (-124 bps) on rising raw-material and traded-goods costs (41.1% of revenue vs 38.7% YoY)
- YoY margin/profit erosion is far narrower than Q1 FY27's 933-bps EBITDA collapse and 34.3% PAT decline, suggesting commodity pass-through pressure is easing
- Revenue beat Street: MOFSL estimate was ~₹1,000 Cr vs actual ₹1,145 Cr (~14-15% ahead)
- A&P spend ₹166.62 Cr (14.55% of revenue) — down YoY from ₹175.97 Cr (15.30%) despite nearly doubling sequentially from Q1's ₹83.32 Cr
- EPS ₹60.33 vs ₹64.65 YoY; company has no subsidiary/associate/JV (Note 8), so standalone is the sole reported basis
Price Impact
More from PGHH